Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
220
44
54
83
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
3.6%
8 terminated/withdrawn out of 220 trials
91.2%
+4.6% vs industry average
7%
15 trials in Phase 3/4
4%
3 of 83 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (220)
Liquid Biopsy Biomarkers for Endoscopic Surveillance in Lynch Syndrome
Role: lead
Role of Tumor Microbiota in the Response to Neoadjuvant Therapy in Patients Affected by Triple Negative Breast Cancer
Role: collaborator
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
Role: collaborator
Surgical Timing After Preoperative Hypofractionated Radiotherapy for Localized Extremity and Trunk Soft Tissue Sarcoma
Role: collaborator
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
Role: collaborator
Late Effects of Cancer Therapies on Gonadal Function, Fertility, Efficiency of Fertility Preservation Procedures and Pregnancy Outcomes
Role: collaborator
Non-invasive Detection of Breast Cancer by Breath Analysis
Role: lead
Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial
Role: collaborator
Assessing Health-related Quality of Life in Sarcoma Patients
Role: collaborator
A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma
Role: lead
Big Data for Quality of Life in Head and Neck Cancer
Role: lead
Epithelioid Haemangioendothelioma Observational Study
Role: lead
Immunological Phenotype of Desmoid-fibromatosis-affected Patients.
Role: lead
Screening and Multiple Intervention on Lung Epidemics
Role: lead
AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs
Role: lead
Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare)
Role: lead
Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib
Role: collaborator
Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
Role: collaborator
Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.
Role: collaborator
Exercise Training in Childhood Cancer
Role: collaborator